Cargando…

Guidelines for the Treatment of Latent Tuberculosis Infection: Recommendations from the National Tuberculosis Controllers Association and CDC, 2020

Comprehensive guidelines for treatment of latent tuberculosis infection (LTBI) among persons living in the United States were last published in 2000 (American Thoracic Society. CDC targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med 2000;161:S221–47)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sterling, Timothy R., Njie, Gibril, Zenner, Dominik, Cohn, David L., Reves, Randall, Ahmed, Amina, Menzies, Dick, Horsburgh, C. Robert, Crane, Charles M., Burgos, Marcos, LoBue, Philip, Winston, Carla A., Belknap, Robert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Centers for Disease Control and Prevention 2020
Materias:	Recommendations and Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7041302/ https://www.ncbi.nlm.nih.gov/pubmed/32053584 http://dx.doi.org/10.15585/mmwr.rr6901a1

Ejemplares similares

Update of Recommendations for Use of Once-Weekly Isoniazid-Rifapentine Regimen to Treat Latent Mycobacterium tuberculosis Infection
por: Borisov, Andrey S., et al.
Publicado: (2018)

Essential Components of a Public Health Tuberculosis Prevention, Control, and Elimination Program: Recommendations of the Advisory Council for the Elimination of Tuberculosis and the National Tuberculosis Controllers Association
por: Cole, Barbara, et al.
Publicado: (2020)

Tuberculosis Screening, Testing, and Treatment of U.S. Health Care Personnel: Recommendations from the National Tuberculosis Controllers Association and CDC, 2019
por: Sosa, Lynn E., et al.
Publicado: (2019)

Highly Multiplexed Proteomic Analysis of Quantiferon Supernatants To Identify Biomarkers of Latent Tuberculosis Infection
por: De Groote, Mary Ann, et al.
Publicado: (2017)

CDC Guidelines for the Prevention and Treatment of Anthrax, 2023
por: Bower, William A., et al.
Publicado: (2023)

Identifying gaps in the quality of latent tuberculosis infection care
por: Hannah, Alsdurf, et al.
Publicado: (2020)

CDC Recommendations for Hepatitis C Screening Among Adults — United States, 2020
por: Schillie, Sarah, et al.
Publicado: (2020)

CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022
por: Dowell, Deborah, et al.
Publicado: (2022)

Recent developments in treatment of latent tuberculosis infection
por: Menzies, Dick, et al.
Publicado: (2011)

Screening and Testing for Hepatitis B Virus Infection: CDC Recommendations — United States, 2023
por: Conners, Erin E., et al.
Publicado: (2023)

Four months of rifampicin monotherapy for latent tuberculosis infection in children
por: Oh, Chi Eun, et al.
Publicado: (2021)

CDC Recommendations for Hepatitis C Testing Among Perinatally Exposed Infants and Children — United States, 2023
por: Panagiotakopoulos, Lakshmi, et al.
Publicado: (2023)

Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force
por: Smolen, Josef S, et al.
Publicado: (2014)

Multinational evidence-based recommendations for the diagnosis and management of gout: integrating systematic literature review and expert opinion of a broad panel of rheumatologists in the 3e initiative
por: Sivera, Francisca, et al.
Publicado: (2014)

The effect of diabetes mellitus on tuberculosis in eastern China: A decision‐tree analysis based on a real‐world study
por: Ling, Yuxiao, et al.
Publicado: (2023)

2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis
por: Braun, J, et al.
Publicado: (2011)

Testing and Clinical Management of Health Care Personnel Potentially Exposed to Hepatitis C Virus — CDC Guidance, United States, 2020
por: Moorman, Anne C., et al.
Publicado: (2020)

Finding and Closing the Gaps in the Tuberculosis Elimination Campaign
por: Reves, Randall
Publicado: (2020)

Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force
por: Smolen, Josef S, et al.
Publicado: (2018)

Development of EULAR recommendations for the reporting of clinical trial extension studies in rheumatology
por: Buch, Maya H, et al.
Publicado: (2015)

Recommendations of the Polish Medical Society of Radiology and the Polish Society of Neurology for the routinely used magnetic resonance imaging protocol in patients with multiple sclerosis
por: Sąsiadek, Marek, et al.
Publicado: (2020)

Bridging Implementation, Knowledge, and Ambition Gaps to Eliminate Tuberculosis in the United States and Globally
por: Castro, Kenneth G., et al.
Publicado: (2011)

Council of State and Territorial Epidemiologists/CDC Surveillance Case Definition for Multisystem Inflammatory Syndrome in Children Associated with SARS-CoV-2 Infection — United States
por: Melgar, Michael, et al.
Publicado: (2022)

Feasibility of an Ingestible Sensor-Based System for Monitoring Adherence to Tuberculosis Therapy
por: Belknap, Robert, et al.
Publicado: (2013)

Multiple Cytokines Are Released When Blood from Patients with Tuberculosis Is Stimulated with Mycobacterium tuberculosis Antigens
por: Kellar, Kathryn L., et al.
Publicado: (2011)

EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update
por: Gossec, Laure, et al.
Publicado: (2020)

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs
por: Smolen, Josef S, et al.
Publicado: (2010)

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update
por: Smolen, Josef S, et al.
Publicado: (2014)

Transmission of Mycobacterium tuberculosis in a High School and School-Based Supervision of an Isoniazid-Rifapentine Regimen for Preventing Tuberculosis — Colorado, 2011–2012
por: Bargman, Carolyn, et al.
Publicado: (2013)

Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force
por: Smolen, Josef S, et al.
Publicado: (2016)

First Latin American clinical practice guidelines for the treatment of systemic lupus erythematosus: Latin American Group for the Study of Lupus (GLADEL, Grupo Latino Americano de Estudio del Lupus)–Pan-American League of Associations of Rheumatology (PANLAR)
por: Pons-Estel, Bernardo A, et al.
Publicado: (2018)

Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries
por: Getahun, Haileyesus, et al.
Publicado: (2015)

Heidelberg Consensus Recommendations on Trustmarks
Publicado: (2000)

Treatment recommendations for psoriatic arthritis
por: Ritchlin, C T, et al.
Publicado: (2009)

EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for Rheumatoid Arthritis
por: Gerlag, Danielle M, et al.
Publicado: (2012)

Treating rheumatoid arthritis to target: the patient version of the international recommendations
por: de Wit, M P T, et al.
Publicado: (2011)

Treating rheumatoid arthritis to target: recommendations of an international task force
por: Smolen, Josef S, et al.
Publicado: (2010)

Updated clinical recommendations for the use of tibolone in Asian women
por: Huang, K-E., et al.
Publicado: (2010)

Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis
por: Bertsias, George K, et al.
Publicado: (2012)

Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative
por: Visser, K, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_v4i67j6it3s2pgqq4aoo4nmceg